The five-year tirzepatide trial is being funded in full by a pharmaceutical company called Lilly, not the taxpayer.

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

The prevalence of obesity continues to remain high in the US making the demand for effective treatments even more urgent.

Amid ongoing legal battles over coveted GLP-1 therapies, a drug vendor in Washington state is accused of running an ...

If you’ve listened to any weight-loss podcasts or watched the news in the past year, you’ve probably heard of the new drugs: ...

Vice President Kamala Harris wants more drugs to be negotiated by Medicare, but her plan to implement an expansion if elected president remains unclear.

WEIGHT-LOSS jabs are the most talked about drugs of the moment. And with new studies popping up almost every week revealing ...

MangoRx said it “strongly refutes” claims made by Eli Lilly that it improperly copied blockbuster weight-loss medicines for ...

Monday’s lawsuits from Eli Lilly are the first to be filed by the pharma since the regulator officially removed tirzepatide ...

You’ve probably heard the chatter about injectable weight-loss medications and found yourself wondering if they might hold ...